Who Owns Grifols Company?

Who Owns Grifols?

Understanding a company's ownership is key to grasping its strategy and market influence. In July 2024, Grifols, a global healthcare firm focused on plasma-derived medicines, saw its founding family and asset manager Brookfield reportedly consider a joint bid to take the company private, a move that significantly affected its stock and highlighted its ownership structure.

Grifols, established in 1909 by Josep Antoni Grífols i Roig in Barcelona, Spain, has evolved from its origins as a clinical analysis laboratory to become a world leader in plasma-derived therapies. The company's commitment to advancing healthcare is evident in its diverse product portfolio, which includes treatments like Grifols BCG Matrix, serving patients across more than 110 countries.

The ownership of Grifols is a complex interplay of its founding family, institutional investors, and public shareholders. This structure has seen notable shifts over time, influencing the company's governance and strategic decisions.

The Grifols company's origins trace back to a humble clinical analysis laboratory established in Barcelona, Spain, in 1909 by Dr. Josep Antoni Grífols i Roig. This hematologist and scientist also pioneered the first instrument for indirect blood transfusions in Spain, laying the groundwork for future innovations.

Founding Family's Scientific Roots

Dr. Josep Antoni Grífols i Roig, a distinguished hematologist, founded the initial laboratory. His sons, Josep Antoni Grífols i Lucas and Víctor Grífols i Lucas, continued the family's scientific legacy.

Establishment of Laboratorios Grifols

In November 1940, the family officially established Laboratorios Grifols. This marked a significant step in the company's dedication to clinical analysis and the development of freeze-dried plasma.

Pioneering Blood Transfusion Technology

Dr. Josep Antoni Grífols i Roig's early work included patenting Spain's first instrument for indirect blood transfusions. This innovation showcased the family's commitment to advancing medical technology.

Generational Leadership Transition

Control of the company transitioned through generations, with Víctor Grífols Roura taking the helm in 1987. This period saw the creation of Grupo Grifols to consolidate various business operations.

Commitment to Patient Care and Science

Early strategic decisions and leadership emphasized scientific expertise and a dedication to serving patients. This foundational principle guided the company's growth and development.

Advancements in Plasmapheresis

Josep Antoni Grífols i Lucas's research contributed significantly to the field, including the systematic application of plasmapheresis in humans. His findings were published in the prestigious British Medical Journal in 1952.

Early Ownership Structure

While specific initial equity splits are not publicly detailed, the Grifols family has maintained significant control throughout the company's history. This family ownership has been a cornerstone of its strategic direction and long-term vision, influencing its approach to innovation and market expansion, as seen in their Marketing Strategy of Grifols.

• The company's foundation was built on scientific expertise.
• Family leadership has been a consistent element in its ownership structure.
• Early focus was on clinical analysis and plasma-derived products.
• Innovation in blood transfusion technology was a key early achievement.

Complete Grifols Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

Grifols, S.A. transitioned to a publicly traded entity in 2006, listing on the Madrid Stock Exchange. Its subsequent trading on NASDAQ in 2011 followed a significant acquisition, marking key milestones in its ownership evolution.

The Grifols family, along with associated entities, continues to exert significant influence over the company, maintaining a substantial ownership stake. This family control is a defining characteristic of Grifols' ownership structure, impacting strategic decision-making and long-term direction. The family's holdings are managed through various investment vehicles, ensuring a consolidated approach to their stake in the company.

Grifols Ownership Landscape

The ownership of Grifols is a blend of founding family control and institutional investment, reflecting its status as a major publicly traded entity.

• As of August 2025, the Grifols family and associates control approximately 30% of the company.
• Key family-linked entities include Scranton Enterprises B.V., Thorthols Holdings B.V., and Rodellar Amsterdam B.V.
• Institutional investors, such as Capital Group, hold significant but fluctuating stakes; Capital Group's stake was 2.902% as of February 2025.
• In 2024, 55.95% of the company's share capital with voting rights was represented by 511 shareholders at the annual general meeting.
• Grifols' 2024 revenues reached €7,212 million.
• By June 6, 2025, Grifols S.A. held 99.25% of the voting rights in Biotest AG.

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

As of July 2025, Grifols' Board of Directors comprises 12 members, including proprietary directors representing significant shareholders and independent directors. Anne-Catherine Berner assumed the role of non-executive Chairperson on June 5, 2025, succeeding Thomas Glanzmann. Nacho Abia is the current Chief Executive Officer, a position he took on April 1, 2024.

The voting power at Grifols is structured through Class A and Class B shares. Class A shares carry voting rights, while Class B shares are entitled to preferred dividends and preferential liquidation shares but lack voting rights. This dual-class system ensures that holders of Class A shares, including the founding family, maintain significant control over company decisions. The Grifols family, through various entities, holds approximately 30% of the company's voting shares, solidifying their position as the Grifols majority owner and underscoring the Grifols family ownership. Recent governance changes, effective June 1, 2024, saw Raimon Grifols and Víctor Grifols Deu transition from executive to proprietary director roles, a move intended to enhance corporate governance and separate ownership from management. Despite these efforts, the company faced scrutiny in early 2024 following allegations from a short-seller that questioned its accounting and debt figures, leading to a notable share price decline. This event prompted increased focus on strengthening corporate governance and addressing related-party transactions, particularly those involving Scranton Enterprises. Concerns regarding corporate governance and potential conflicts of interest have been voiced by minority shareholders, such as Mason Capital Management, who advocate for more independent directors to improve oversight and unlock shareholder value. The June 2025 General Shareholders' Meeting approved key resolutions, including the appointment of Anne-Catherine Berner as non-executive Chair, the re-election of Víctor Grífols Deu, and the designation of Paul S. Herendeen as a proprietary director by a group of minority shareholders. The board also decided to reduce its size to 12 members.

Grifols Ownership and Governance

Understanding Grifols ownership involves recognizing the dual-class share structure and the significant influence of the founding family. Recent governance changes aim to bolster oversight and transparency.

• Grifols operates with a dual-class share structure (Class A and Class B).
• Class A shares hold voting rights, while Class B shares have preferential dividend rights.
• The Grifols family controls approximately 30% of the company's voting shares.
• Recent governance changes aim to separate executive management from board representation.
• Minority shareholders are advocating for increased independent director representation.

Grifols Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

Recent developments at Grifols indicate significant shifts in its leadership and ownership structure over the past 12-18 months. These changes aim to enhance corporate governance and separate ownership from day-to-day management, reflecting evolving industry expectations for transparency and accountability.

In July 2024, a potential joint takeover bid by the Grifols founding family and Brookfield emerged, signaling a possible move to take the company private. This interest followed a significant market value decline of approximately €3.2 billion after a short-seller report in January 2024. These actions suggest a strategic consideration to stabilize the company away from public market pressures, impacting the Grifols ownership profile.

Financial Performance and Deleveraging

Grifols reported revenues of €7,212 million in 2024, surpassing expectations. The company has actively worked on deleveraging, reducing its leverage ratio to 4.2x by the first half of 2025, a notable decrease from 5.5x in the first half of 2024. The company also reaffirmed its 2025 guidance for Free Cash Flow pre-M&A, projecting €375-425 million.

Corporate Governance and Industry Trends

The company is addressing corporate governance, particularly related-party transactions, to enhance transparency and investor confidence. These efforts align with industry trends that place increased scrutiny on family-controlled public companies, influencing Grifols' corporate structure ownership.

Stakeholder Interests and Ownership

The potential privatization bid highlights the Grifols family's continued significant interest in the company's direction. This move could reshape Grifols' stock ownership breakdown and its status as a publicly traded company.

Strategic Realignment and Shareholder Value

Grifols' focus on debt reduction and cash flow generation demonstrates a commitment to financial stability. These strategic decisions are crucial for maximizing returns and are key aspects of the Growth Strategy of Grifols.

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE